Dravet syndrome (DS) is a severe pediatric epileptic encephalopathy with disease onset in the first year of life. Patients have normal presentation before seizure onset and then experience frequent seizures, ataxia, cognitive deficits, and a high risk of sudden unexpected death in epilepsy (1). The majority of DS cases are caused by de novo loss-of-function mutations in SCN1A, encoding the voltage-gated sodium channel Na v 1.1, resulting in haploinsufficiency (2) (3) (4) .
Scn1a −/+ hippocampal pyramidal neuron excitability compared to wildtype (WT), while interneuron excitability is decreased before and after disease onset (9) . Regardless of contributions from other neuron types, interneurons are involved in various network oscillations, suggesting their dysfunction should translate to dramatic network effects in vivo (10) .
In their article in Cerebral Cortex, De Stasi et al. set out to address the in vivo network impacts of SCN1A-linked DS in mice. In vivo local field potential (LFP) and multiunit activity (MUA) recordings were performed in the somatosensory cortex of P16 to 18 WT and Scn1a −/+ mice. Importantly, Scn1a −/+ mice in this age range have not yet begun to exhibit seizures and have been shown using whole cell patch clamp in acute brain slices to have hypoexcitability of parvalbumin positive (PV+) and somatostatin positive (SOM+) interneurons of the cortex and hippocampus (4, 5, 9) . Here, under urethane anesthesia, De Stasi et al. demonstrated that the only differences in the LFP power spectrum between genotypes are modest reductions in the δ (2-4 Hz) and θ (4-8 Hz) frequency bands when recording from superficial cortical layers. In deep layer recordings, no differences were found between genotypes in the LFP power spectrum at any frequency. To test if the subtle differences were due to anesthesia, experiments were repeated in awake animals; however, no differences were found in the LFP power spectrum at any frequency. In addition, no differences in neuronal spiking were detected in the MUA signal Severe myoclonic epilepsy of infancy (SMEI) is associated with loss of function of the SCN1A gene encoding the NaV1.1 sodium channel isoform. Previous studies in Scn1a −/+ mice during the pre-epileptic period reported selective reduction in interneuron excitability and proposed this as the main pathological mechanism underlying SMEI. Yet, the functional consequences of this interneuronal dysfunction at the circuit level in vivo are unknown. Here, we investigated whether Scn1a −/+ mice showed alterations in cortical network function. We found that various forms of spontaneous network activity were similar in Scn1a −/+ during the pre-epileptic period compared with wild-type (WT) in vivo. Importantly, in brain slices from Scn1a −/+ mice, the excitability of parvalbumin (PV) and somatostatin (SST) interneurons was reduced, epileptiform activity propagated more rapidly, and complex synaptic changes were observed. However, in vivo, optogenetic reduction of firing in PV or SST cells in WT mice modified ongoing network activities, and juxtasomal recordings from identified PV and SST interneurons showed unaffected interneuronal firing during spontaneous cortical dynamics in Scn1a −/+ compared with WT. These results demonstrate that interneuronal hypoexcitability is not observed in Scn1a −/+ mice during spontaneous activities in vivo and suggest that additional mechanisms may contribute to homeostatic rearrangements and the pathogenesis of SMEI.
Expecting the Unexpected: Lack of In Vivo Network Defects in an Scn1a Model of Dravet Syndrome
under any of the above conditions. Importantly, these results are counter to the dramatic effects predicted from previous work in DS mouse brain slices.
To test for the presence of interneuron hypoexcitability, De Stasi et al. recorded action potentials (APs) using whole cell patch clamp from PV+ and SOM+ neurons in somatosensory cortex in acute brain slices. Their findings reflect previous results, showing hypoexcitability of PV+ and SOM+ DS neurons with no change in pyramidal neuron excitability (5, 9) . They also show that DS brain slices have faster propagation of ictal discharges. The authors then tested for differences in PV+ and SOM+ neuron firing rates in vivo with two photon-guided juxtasomal recordings in anesthetized mice. They found no differences between genotypes in spontaneous firing rates or in the average distribution and coefficient of variation in interspike intervals in PV+ or SOM+ neurons. These results suggest that observations of neuronal hypoexcitability measured in brain slices may not translate to reduced spontaneous firing in vivo at P16 to 18. This may be due to the in vivo interneuron firing rates recorded here not reaching rates where a deficit would be apparent in slice recordings (only 10-15% of PV+ and 1-3% of SOM+ neuron APs reach instantaneous rates >50 Hz).
To test the possibility that LFP recordings are unable to detect network level differences, the authors next used optogenetic inhibition of PV+ or SOM+ neuron activity in vivo to validate that, if present, differences could be detected. Their results show that acute inhibition of either neuronal population translates readily to a detectable difference in the LFP power spectrum in WT mice in vivo. The silencing of PV+ neurons provides a broad-spectrum increase in power with the strongest effect in the γ frequency (30-90 Hz) band, with SOM+ neuron inhibition having similar but distinct effects. A possible explanation for why single neuron excitability in brain slices does not translate to differences in spontaneous activity in vivo is that altered synaptic strength or number offsets interneuron hypoexcitability. De Stasi et al. used whole-cell voltage clamp recordings in acute brain slices to measure spontaneous excitatory and inhibitory postsynaptic currents (sEPSCs/sIPSCs) in pyramidal, PV+, and SOM+ neurons. They found increased sEPSC amplitude in pyramidal neurons and increased sIPSC amplitude in PV+ neurons with no alterations in sEPSC or sIPSC frequency in any cell type measured. Rather than countering excitability reductions of PV+ and SOM+ neurons, their results instead argue for an exacerbation of network hyperexcitability. The authors proposed that the discrepancy between slice and in vivo data could be a result of the nonphysiological synaptic drive and AP generation with whole-cell recording in acute brain slices. It is important, however, to temper the interpretation of optogenetic inhibition versus intrinsic hypoexcitability, as optogenetics is the network equivalent of a "sledgehammer, " inhibiting many target neurons simultaneously and across the entire span of the neuron's structure.
Regardless, the effect of PV+ neuron optogenetic inhibition is particularly interesting, as previous work in cortex has shown that optogenetic stimulation of PV+ neurons increases γ power and inhibition of PV+ neurons decreases γ power, rather than increasing it, as shown in Cardin et al. (11) and Sohal et al. (12) . While this may appear to be a discrepancy, it is important to note that those recordings were performed in mice at 6 to 12 weeks and >7 weeks of age, respectively (11, 12) , while those performed by De Stasi et al. were 3 to 4 weeks of age. This may provide a clue as to why interneuron hypoexcitability at P15 to 18 does not result in seizures or large differences in the LFP power spectrum. This age range marks the onset of maturation of both GABAergic and glutamatergic signaling in mouse brain. The density of glutamatergic synapses increases, taking over as the main depolarizing drive, while GABA switches from depolarizing to hyperpolarizing through a reversal of Cl-gradients. This switch occurs concomitantly with the appearance of physiological (and possibly pathophysiological) high-frequency oscillations (HFOs) of >100 Hz in cortex and hippocampus, which are known to engage PV+ interneurons at high firing rates (13) . For a review of the relationship between HFOs, GABAergic maturation, and epilepsy, see Le Van Quyen et al. (13) . Notably, HFOs are not reported here, possibly reflecting their absence at this age.
Should a lack of in vivo network level deficits at P16 to 18 in Scn1a +/mice, prior to seizure onset, be surprising? A comparison of nonseizure oscillations in DS patients' EEGs shows that deficits are subtle at the start of pathology and not pronounced until deep into the epileptic period (14) . If not unexpected from a clinical perspective, are the results here unexpected from a network physiology perspective? In hindsight, no. Because GABAergic signaling is still developing at P16 to 18, it is not surprising that impaired interneuron function does not affect oscillations typically impacted by interneurons measured after maturation. Despite reporting only subtle network differences, this paper is extremely informative. It highlights that interneuron hypoexcitability does not cause network level defects at this developmental age range in mice, suggesting that another substrate is necessary to generate pathology. Some possibilities include pyramidal neuron hyperexcitability, further network maturation, or a pathological insult such as fever. This work opens the door to further investigations of the in vivo impacts of DS. Furthermore, it is a powerful reminder of the importance of in vivo network physiology when considering epilepsy mechanisms.
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